
Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
Author(s) -
Yue Zhang,
Yifan Wu,
Zhendong Yue,
Hongwei Zhao,
Lei Wang,
Zhaoqing Fan,
Fuliang He,
Tao Wang,
Fuquan Liu
Publication year - 2019
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v11.i4.310
Subject(s) - medicine , transjugular intrahepatic portosystemic shunt , hepatocellular carcinoma , stent , surgery , complication , restenosis , radiology , stenosis , thrombus , embolization , neointimal hyperplasia , portal hypertension , cirrhosis , gastroenterology
Main portal vein tumor thrombus (MPVTT), which has a high incidence, is the major complication of terminal liver cancer. The occurrence of MPVTT is always a negative prognostic factor for patients with hepatocellular carcinoma (HCC). Therefore, attention should be paid to the treatment of MPVTT and its complications.